Article info
PDFStructured abstracts of sentinel articles: Picket
Rituximab is more effective than tacrolimus in steroid-dependent nephrotic syndrome
- Correspondence to Dr Alex D Lalayiannis, Paediatric Nephrology, Great Ormond Street Hospital for Children NHS Foundation Trust, London WC1N 3JH, UK; alex.lalayiannis{at}nhs.net
Citation
Rituximab is more effective than tacrolimus in steroid-dependent nephrotic syndrome
Publication history
- First published February 1, 2019.
Online issue publication
September 20, 2019
Article Versions
- Previous version (20 September 2019).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© Author(s) (or their employer(s)) 2019. No commercial re-use. See rights and permissions. Published by BMJ.